Fasken Martineau DuMoulin LLP represented OnCall on the deal while Orrick advised Qualifacts. On November 1, 2022, Qualifacts Systems, LLC (“Qualifacts”), a leading provider of behavioural...
Qualifacts Systems’ Acquisition of OnCall Health Inc.
Beringer Capital’s Acquisition of Majority Stake in Dig Insights
Fasken Martineau DuMoulin LLP advised Dig Insights on the matter. On September 1, 2022, tech-enabled insight and strategy consultancy, Dig Insights, completed the sale of a...
Level Access’s Merger With eSSENTIAL Accessibility
Fasken Martineau DuMoulin LLP acted for eSSENTIAL Accessibility. Latham & Watkins represented KKR in the transaction. Level Access, the trusted provider of enterprise digital accessibility solutions, and eSSENTIAL...
Elemental Royalties Corp.’s Merger with Altus Strategies Plc
Elemental’s financial advisor was Canaccord Genuity Limited, assisted by Wildeboer Dellelce LLP. Fasken Martineau DuMoulin LLP acted as legal counsel to Elemental. Longview Communications and Public...
Real Estate Split Corp.’s C$10.1 Million Public Offering
Fasken Martineau DuMoulin LLP advised Middlefield Limited, the manager of the Fund. McCarthy Tétrault advised CIBC World Markets Inc. On June 29, 2022 Real Estate Split...
Real Estate Split Corp.’s C$10.1 Million Public Offering
Fasken Martineau DuMoulin LLP advised Middlefield Limited, the manager of the Fund. McCarthy Tétrault advised CIBC World Markets Inc. On June 29, 2022 Real Estate Split...
Real Estate Split Corp.’s C$10.1 Million Public Offering
Fasken Martineau DuMoulin LLP advised Middlefield Limited, the manager of the Fund. McCarthy Tétrault advised CIBC World Markets Inc. On June 29, 2022 Real Estate Split...
Algernon Pharmaceuticals Inc.’s C$1.1 Million Public Offering
Fasken Martineau DuMoulin LLP advised the sole agent and sole bookrunner. On July 4, 2022, Algernon Pharmaceuticals Inc. (CNSX:AGN) announced the closing of its previously announced marketed...
GeneTether Therapeutics Inc.’s C$4.5 Million Initial Public Offering
Fasken Martineau DuMoulin LLP advised Research Capital Corporation on the matter. GeneTether Therapeutics Inc. (CSE: GTTX), an innovative genetic medicines company, completed an initial public offering of...
Amex Exploration Inc.’s C$49.6 Million Bought Deal Private Placement
Fasken Martineau DuMoulin LLP acted for the underwriters. Amex Exploration Inc. (CVE:AMX) , a junior mining exploration company, closed a bought deal private placement in the amount of...
Ascot Resources Ltd.’s C$64 Million Bought Deal Offering
Fasken Martineau DuMoulin LLP assisted the underwriters. Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) closed its previously announced C$64 million bought deal financing. The Offering consisted of (i)...
Talisker Resources Ltd.’s $12.5 Million Bought Deal Private Placement
Cassels Brock & Blackwell LLP acted for Talisker Resources Ltd. Fasken Martineau DuMoulin LLP assisted the syndicate of underwriters. Talisker Resources Ltd. (TSE:TSK) closed a bought deal...